Preclinical Study Management Built for Rigor and Reproducibility

Unify study design, execution, data quality, and reporting in a single platform—purpose-built for preclinical research and enhanced with governed AI assistance.

One Platform for the Full Study Lifecycle

Seralogix supports preclinical studies from initial design through execution, analysis, reporting, and archival—while maintaining validation, traceability, and real-time visibility at every stage.

Issues are identified early, progress is visible in real time, and every decision is traceable back to the original study design.

How the Seralogix Platform Supports the Study Lifecycle

Seralogix implements the preclinical study lifecycle through a set of tightly integrated functional modules—each designed to support a specific phase of research while remaining connected as a single system.

Select a module to explore how Seralogix supports each stage of the study lifecycle.

Together, these modules ensure that every study action is visible, validated, and traceable back to the original experimental design.

Preclinical Research Deserves More Than Disconnected Tools

Many preclinical studies fail not because of effort or intent—but because experimental design, execution, and data validation are insufficiently supported by the tools used to run them.

Inadequate study design and poorly supported assumptions can lead to unreliable, non-reproducible results. Issues such as outliers, missing data, or protocol deviations are often discovered too late—after decisions have already been made or studies must be repeated at significant cost.

Without real-time visibility, automated validation, and guided workflows, teams struggle to detect problems early, track progress effectively, and produce accurate, review-ready reports without extensive manual effort.

Weak or Unsupported Experimental Design

Insufficient guidance around assumptions, variability, and study structure leads to unreliable results and poor reproducibility.

Problems Discovered Too Late

Outliers, missing data, and protocol deviations often surface only after data collection is complete—when correction is costly or impossible.

Manual, Opaque Execution

Without real-time task tracking, validation, and reporting support, teams lose visibility into progress and spend weeks assembling results manually.

Designed for scientists, study leaders, and research organizations that need defensible assumptions, consistent execution, and faster decisions.

Designed Around Studies — Not Samples or Case Report Forms

Unlike general-purpose LIMS or clinical EDC systems, Seralogix is built specifically to manage the full preclinical study lifecycle—so rigor, traceability, and reporting readiness are part of the workflow from day one.

Study Intelligence Built Into the Workflow

AI assistance that strengthens scientific judgment—before execution begins.

Many downstream study issues originate at the design stage—unsupported assumptions, unclear endpoints, or inappropriate statistical models. Seralogix addresses these risks before data collection begins by embedding AI-assisted guidance directly into experimental design workflows.

As studies are designed, Seralogix provides contextual, evidence-informed assistance—highlighting design implications, validating assumptions, and identifying potential risks early. This guidance is transparent, reviewable, and always under human control.

The result is greater confidence from the beginning: fewer late-stage surprises, more defensible assumptions, and studies that are designed to produce reliable, reproducible results from the outset.

Design Implications Made Explicit

Selections such as shared subjects, repeated measures, or secondary factors are interpreted in context so design consequences are clear early.

Evidence-Informed Assumptions

Leverage public reference data or prior internal studies to refine effect size and variability assumptions without overwriting scientific judgment.

Human-in-the-Loop by Design

All AI guidance is explainable, reviewable, and advisory—final decisions always remain with the study team.

Confidence is built by connecting design, execution, and analysis into a single, traceable workflow.

Confidence Begins at Study Design

AI assistance that strengthens scientific judgment—before execution begins.

Seralogix structures studies around proven experimental design patterns and strengthens assumptions using prior evidence—so rigor improves over time, not just within a single study. Teams can leverage public reference datasets and their own historical results to refine effect size and variability estimates, while maintaining full traceability and version history.

Design Patterns, Not Just Forms

Choose validated study patterns—t-tests, repeated measures, ANOVA, factorial designs—and Seralogix guides structure, timelines, and required fields so the workflow matches the science.

Evidence-Informed Assumptions

Link response factors to prior results from public datasets or your organization’s history to refine variability and effect size assumptions—without overwriting scientific judgment.

Iterative Refinement Over Time

Update assumptions as new data accumulates, compare scenarios, and preserve versioned decisions—so studies improve continuously while maintaining audit-ready traceability.

How Study Intelligence Works in Practice

Start with a study design pattern

study driven objects and goals sets testing requirements (e.g., t-test, repeated measures, factorial)

Strengthen assumptions with prior evidence

Improved assumptions improves the power of a study (e.g., effect size, outcome response variability, other sources of variability)

Validate in real time during execution

Avoid costly study repeats by catching errors early in execution (outliers, missing data, unexpected deviations)

AI You Can Trust in Scientific Research

Seralogix embeds AI as a governed, assistive capability—designed to support scientific judgment, not replace it. AI recommendations are transparent, reviewable, and always under human control, ensuring confidence in both the process and the results.

What AI Does

What AI Does Not Do

Governance by Design

AI in Seralogix is designed to amplify scientific rigor—never to bypass it.

WHO IT'S FOR

Built for Every Role in Preclinical Research

See how Seralogix helps teams design better studies, detect issues earlier, and make confident decisions—without sacrificing scientific judgment or flexibility.

OUTCOMES

Outcomes That Matter in Preclinical Research

By strengthening study design, enforcing consistent execution, and embedding intelligence throughout the workflow, Seralogix helps organizations improve confidence in results while reducing rework, delays, and downstream risk.

ionicons-v5-s

Improved Scientific Confidence

More defensible assumptions, consistent execution, and traceable decisions increase confidence in study conclusions.

Earlier Issue Detection

Real-time validation and monitoring surface outliers, missing data, and deviations before they become costly problems.

Faster, More Reliable Reporting

Standardized workflows and structured outputs reduce manual reporting effort and accelerate review readiness.

Better Decisions at Portfolio Scale

Clear visibility across studies and programs supports timely, informed decisions without waiting for post hoc summaries.

Outcomes vary by organization and implementation maturity, but the foundation for rigor, visibility, and continuous improvement remains consistent.

MOVE INTO THE FUTURE

Bring Structure, Confidence, and Clarity to Preclinical Research

See how Seralogix helps teams design better studies, detect issues earlier, and make confident decisions—without sacrificing scientific judgment or flexibility.